Simcere Pharmaceutical Group Limited (HKG:2096)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
12.55
+0.20 (1.62%)
Aug 11, 2026, 1:14 PM HKT

HKG:2096 Stock Forecast

Stock Price Forecast

According to 6 analysts polled by S&P Global, HKG:2096 stock has a consensus rating of "Buy" and an average price target of $17.82. The average 1-year stock price forecast is 41.99% higher than the current stock price, while the lowest is $12.46 (-0.72%) and the highest is $21.35 (+70.12%).

Price Target: $17.82 (+41.99%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$12.46$17.82$18.73$21.35
Change-0.72%+41.99%+49.24%+70.12%

Analyst Ratings

The average analyst rating for HKG:2096 stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingFeb '26Mar '26Apr '26May '26Jun '26Jul '26
Strong Buy444444
Buy000111
Hold111111
Sell000000
Strong Sell000000
Total555666

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Unknown Analyst
Huatai Securities
No rating
Huatai Securities
Buy
Maintains
$21.32
BuyMaintains$21.32+69.88%Aug 2, 2026
Unknown Analyst
UBS
No rating
UBS
Buy
Maintains
$16.30
BuyMaintains$16.30+29.88%Jul 31, 2026
Unknown Analyst
Citic Securities
No rating
Citic Securities
Buy
Maintains
$20.00
BuyMaintains$20.00+59.36%Jun 2, 2026
Unknown Analyst
Bank of China
No rating
Bank of China
Buy
Maintains
$17.00
BuyMaintains$17.00+35.46%Mar 31, 2026
Unknown Analyst
BOCOM International Holdings Company
No rating
BOCOM International Holdings Company
Buy
Maintains
$17.70
BuyMaintains$17.70+41.04%Mar 30, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
10.30B
from 7.73B
Increased by 33.25%
Revenue Next Year
11.64B
from 10.30B
Increased by 12.96%
EPS This Year
5.17
from 3.54
Increased by 45.95%
EPS Next Year
5.05
from 5.17
Decreased by -2.43%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
5.00B6.32B6.61B6.64B7.73B10.30B
Revenue Growth
10.89%26.49%4.49%0.42%16.52%33.25%
Gross Profit
3.92B5.00B4.98B5.32B6.31B8.44B
Gross Margin
78.40%79.01%75.43%80.25%81.61%81.93%
Operating Income
233.33M606.34M710.84M1.12B1.42B2.28B
Net Income
1.51B930.87M714.76M722.00M1.34B1.70B
EPS
----3.545.17
EPS Growth
----77.34%45.95%
Forward PE
26.6329.0412.1114.3516.582.09
Dividend / Share
0.150.160.160.160.182.44
Dividend Growth
-6.67%--12.50%1,255.72%
Free Cash Flow
438.89M175.48M-1.05B429.35M776.72M618.19M
No. Analysts
-----5
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.

Revenue Forecast

Revenue202620272028
High10.5B
Avg10.3B
Low10.2B

Revenue Growth

Revenue Growth202620272028
High
35.5%
Avg
33.2%
Low
31.7%

EPS Forecast

EPS202620272028
High7.44
Avg5.17
Low4.34

EPS Growth

EPS Growth202620272028
High
110.0%
Avg
46.0%
Low
22.5%